Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Increase (Decrease) in Other Operating Assets

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Increase (Decrease) in Other Operating Assets

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Increase (Decrease) in Other Operating Assets of -$3.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-06

  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$6.54M.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $2.98M, a 253.97% increase year-over-year.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$1.45M.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$5.29M.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for fiscal 2025 was -$10.63M.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for fiscal 2024 was -$2.54M, a 200.08% decline from fiscal 2023.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for fiscal 2023 was $2.54M, a 76.53% decline from fiscal 2022.
  • PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in other operating assets for fiscal 2022 was $10.81M, a 126.94% increase from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Assets 3 monthIncrease (Decrease) in Other Operating Assets 6 monthIncrease (Decrease) in Other Operating Assets 6 month as first filedIncrease (Decrease) in Other Operating Assets 9 monthIncrease (Decrease) in Other Operating Assets 12 monthIncrease (Decrease) in Other Operating Assets 12 month as first filed
2026-06-30-$6.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$3.55M
10-Q · filed 2026-08-06
-$5.00M
derived: sum of 3 quarters · filed 2026-08-06
-$10.30M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$2.98M
10-Q · filed 2026-05-07
$1.53M
derived: sum of 2 quarters · filed 2026-05-07
-$3.76M
derived: sum of 3 quarters · filed 2026-05-07
-$8.49M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$6.75M
derived: sum of 2 quarters · filed 2026-02-27
-$11.47M
derived: sum of 3 quarters · filed 2026-08-06
-$10.63M
10-K · filed 2026-02-27
2025-09-30-$5.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$10.02M
derived: sum of 2 quarters · filed 2026-08-06
-$9.18M
10-Q · filed 2025-11-06
-$10.95M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$4.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$3.88M
10-Q · filed 2026-08-06
-$5.65M
derived: sum of 3 quarters · filed 2026-08-06
-$11.86M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$843.00K
10-Q · filed 2026-05-07
-$928.00K
derived: sum of 2 quarters · filed 2026-05-07
-$7.13M
derived: sum of 3 quarters · filed 2026-05-07
-$3.33M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$7.97M
derived: sum of 2 quarters · filed 2026-02-27
-$4.18M
derived: sum of 3 quarters · filed 2026-02-27
-$2.54M
10-K · filed 2026-02-27
2024-09-30-$6.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$2.41M
derived: sum of 2 quarters · filed 2025-11-06
-$768.00K
10-Q · filed 2025-11-06
-$5.05M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$3.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$5.43M
10-Q · filed 2025-08-04
$1.15M
derived: sum of 3 quarters · filed 2026-02-27
-$119.00K
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$1.64M
10-Q · filed 2025-05-08
-$2.65M
derived: sum of 2 quarters · filed 2026-02-27
-$3.91M
derived: sum of 3 quarters · filed 2026-02-27
-$1.76M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$5.55M
derived: sum of 2 quarters · filed 2026-02-27
-$3.40M
derived: sum of 3 quarters · filed 2026-02-27
$2.54M
10-K · filed 2026-02-27
2023-09-30-$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$889.00K
derived: sum of 2 quarters · filed 2024-11-12
$6.82M
10-Q · filed 2024-11-12
$12.64M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$2.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$8.09M
10-Q · filed 2024-08-08
$8.61M
10-Q · filed 2023-08-03
$13.90M
derived: sum of 3 quarters · filed 2025-02-27
$10.63M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$5.93M
10-Q · filed 2024-05-08
$11.75M
derived: sum of 2 quarters · filed 2025-02-27
$8.47M
derived: sum of 3 quarters · filed 2025-02-27
$9.64M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$5.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$2.54M
derived: sum of 2 quarters · filed 2025-02-27
$3.71M
derived: sum of 3 quarters · filed 2025-02-27
$10.81M
10-K · filed 2025-02-27
2022-09-30-$3.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$2.11M
derived: sum of 2 quarters · filed 2023-11-02
$5.00M
10-Q · filed 2023-11-02
$3.47M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$1.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$8.27M
10-Q · filed 2023-08-03
$6.75M
derived: sum of 3 quarters · filed 2024-02-22
$5.63M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$7.10M
10-Q · filed 2023-05-04
$5.58M
derived: sum of 2 quarters · filed 2024-02-22
$4.46M
derived: sum of 3 quarters · filed 2024-02-22
$6.61M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$2.64M
derived: sum of 2 quarters · filed 2024-02-22
-$496.00K
derived: sum of 3 quarters · filed 2024-02-22
$4.76M
10-K · filed 2024-02-22
2021-09-30-$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$1.03M
derived: sum of 2 quarters · filed 2022-11-03
$6.29M
10-Q · filed 2022-11-03
$4.20M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$7.40M
10-Q · filed 2022-08-08
$5.31M
derived: sum of 3 quarters · filed 2023-02-28
$2.79M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$5.26M
10-Q · filed 2022-05-05
$3.16M
derived: sum of 2 quarters · filed 2023-02-28
$647.00K
derived: sum of 3 quarters · filed 2023-02-28
$129.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$4.61M
derived: sum of 2 quarters · filed 2023-02-28
-$5.13M
derived: sum of 3 quarters · filed 2023-02-28
-$852.00K
10-K · filed 2023-02-28
-$799.00K
10-K · filed 2021-02-26
2020-09-30-$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$3.03M
derived: sum of 2 quarters · filed 2021-11-04
$1.24M
10-Q · filed 2021-11-04
-$14.60M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30-$518.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$3.76M
10-Q · filed 2021-08-05
-$12.08M
derived: sum of 3 quarters · filed 2022-02-25
-$12.64M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$4.28M
10-Q · filed 2021-05-11
-$11.56M
derived: sum of 2 quarters · filed 2022-02-25
-$12.12M
derived: sum of 3 quarters · filed 2022-02-25
$3.42M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$15.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$16.40M
derived: sum of 2 quarters · filed 2022-02-25
-$861.00K
derived: sum of 3 quarters · filed 2022-02-25
-$807.00K
10-K · filed 2022-02-25
2019-09-30-$560.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$14.98M
derived: sum of 2 quarters · filed 2020-11-04
$15.03M
10-Q · filed 2020-11-04
$11.31M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$15.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$15.59M
10-Q · filed 2020-08-06
$11.87M
derived: sum of 3 quarters · filed 2021-02-26
$9.45M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$54.00K
10-Q · filed 2020-05-06
-$3.67M
derived: sum of 2 quarters · filed 2021-02-26
-$6.09M
derived: sum of 3 quarters · filed 2021-02-26
-$8.66M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
-$6.15M
derived: sum of 2 quarters · filed 2021-02-26
-$8.72M
derived: sum of 3 quarters · filed 2021-02-26
-$9.14M
10-K · filed 2021-02-26
2018-09-30-$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$4.99M
derived: sum of 2 quarters · filed 2019-11-05
-$5.41M
10-Q · filed 2019-11-05
-$9.28M
derived: sum of 4 quarters · filed 2020-03-03
2018-06-30-$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$2.99M
10-Q · filed 2019-08-06
-$6.86M
derived: sum of 3 quarters · filed 2020-03-03
-$4.42M
derived: sum of 4 quarters · filed 2020-03-03
2018-03-31-$422.00K
10-Q · filed 2019-05-07
-$4.29M
derived: sum of 2 quarters · filed 2020-03-03
-$1.85M
derived: sum of 3 quarters · filed 2020-03-03
$1.44M
derived: sum of 4 quarters · filed 2020-03-03
2017-12-31-$3.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03
-$1.43M
derived: sum of 2 quarters · filed 2020-03-03
$1.86M
derived: sum of 3 quarters · filed 2020-03-03
$7.31M
10-K · filed 2020-03-03
$7.25M
10-K · filed 2018-02-26
2017-09-30$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$5.73M
derived: sum of 2 quarters · filed 2018-11-06
$11.18M
10-Q · filed 2018-11-06
$6.86M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$3.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$8.74M
10-Q · filed 2018-08-07
$4.42M
derived: sum of 3 quarters · filed 2019-03-15
$3.05M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$5.45M
10-Q · filed 2018-05-09
$1.13M
derived: sum of 2 quarters · filed 2019-03-15
-$242.00K
derived: sum of 3 quarters · filed 2019-03-15
$908.00K
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$4.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$5.69M
derived: sum of 2 quarters · filed 2019-03-15
-$4.54M
derived: sum of 3 quarters · filed 2019-03-15
-$3.36M
10-K · filed 2019-03-15
2016-09-30-$1.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$217.00K
derived: sum of 2 quarters · filed 2017-11-07
$964.00K
10-Q · filed 2017-11-07
$2.21M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$2.33M
10-Q · filed 2017-08-09
$3.57M
derived: sum of 3 quarters · filed 2018-02-26
$4.83M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$1.18M
10-Q · filed 2017-05-09
$2.42M
derived: sum of 2 quarters · filed 2018-02-26
$3.68M
derived: sum of 3 quarters · filed 2018-02-26
$3.05M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$2.50M
derived: sum of 2 quarters · filed 2018-02-26
$1.87M
derived: sum of 3 quarters · filed 2018-02-26
$937.00K
10-K · filed 2018-02-26
2015-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$629.00K
derived: sum of 2 quarters · filed 2016-11-02
-$304.00K
10-Q · filed 2016-11-02
$1.94M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$627.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02
-$1.56M
10-Q · filed 2016-08-02
$680.00K
derived: sum of 3 quarters · filed 2017-02-27
$654.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$933.00K
10-Q · filed 2016-05-04
$1.31M
derived: sum of 2 quarters · filed 2017-02-27
$1.28M
derived: sum of 3 quarters · filed 2017-02-27
$712.00K
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$2.21M
derived: sum of 2 quarters · filed 2017-02-27
$1.65M
derived: sum of 3 quarters · filed 2017-02-27
$2.35M
10-K · filed 2017-02-27
2014-09-30-$26.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
-$595.00K
derived: sum of 2 quarters · filed 2015-11-02
$112.00K
10-Q · filed 2015-11-02
$760.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$569.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$138.00K
10-Q · filed 2015-08-05
$786.00K
derived: sum of 3 quarters · filed 2016-02-25
$585.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$707.00K
10-Q · filed 2015-05-06
$1.35M
derived: sum of 2 quarters · filed 2016-02-25
$1.15M
derived: sum of 3 quarters · filed 2016-02-25
$1.16M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$648.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$447.00K
derived: sum of 2 quarters · filed 2016-02-25
$450.00K
derived: sum of 3 quarters · filed 2016-02-25
$721.00K
10-K · filed 2016-02-25
2013-09-30-$201.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
-$198.00K
derived: sum of 2 quarters · filed 2014-11-04
$73.00K
10-Q · filed 2014-11-04
$517.00K
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30$3.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
$274.00K
10-Q · filed 2014-08-05
$718.00K
derived: sum of 3 quarters · filed 2015-03-13
$735.00K
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31$271.00K
10-Q · filed 2014-05-05
$715.00K
derived: sum of 2 quarters · filed 2015-03-13
$732.00K
derived: sum of 3 quarters · filed 2015-03-13
$706.00K
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31$444.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
$461.00K
derived: sum of 2 quarters · filed 2015-03-13
$435.00K
derived: sum of 3 quarters · filed 2015-03-13
$467.00K
10-K · filed 2015-03-13
2012-09-30$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$9.00K
derived: sum of 2 quarters · filed 2013-11-12
$23.00K
10-Q · filed 2013-11-12
2012-06-30-$26.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
$6.00K
10-Q · filed 2013-08-13
2012-03-31$32.00K
10-Q · filed 2013-05-15
2011-12-31$0.00
10-K · filed 2014-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10